title: [Intravenous clomipramine for depressive disorders].
abstract: 51 patients with depressive episode (40--recurrent depressive disorder, 11--bipolar affective disorder) were treated by the clomipramine intravenous infusions. The number of infusions varied from 5 to 21 (mostly 10-16). The median of maximal dose was 150 mg. There were significant clinical improvement measured by CGI. The therapy was well tolerated.
authors.affiliation: I Klinika Chorób Psychicznych AM w Gdańsku.
authors.forename: Jerzy
authors.initials: J
authors.lastname: Landowski
authors.forename: Ewa
authors.initials: E
authors.lastname: Lamparska
authors.forename: Hubert
authors.initials: H
authors.lastname: Wichowicz
authors.forename: Dorota
authors.initials: D
authors.lastname: Gizińska
authors.forename: Beata
authors.initials: B
authors.lastname: Godlewska
authors.forename: Mariusz
authors.initials: M
authors.lastname: Wiglusz
mesh_terms: D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002997:Clomipramine / Q000008:administration & dosage*; D003866:Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000929:Antidepressive Agents, Tricyclic; D002997:Clomipramine; D017367:Selective Serotonin Reuptake Inhibitors